ATE458724T1 - N-heterocyclische inhibitoren der expression von tnf-alpha - Google Patents

N-heterocyclische inhibitoren der expression von tnf-alpha

Info

Publication number
ATE458724T1
ATE458724T1 AT02739978T AT02739978T ATE458724T1 AT E458724 T1 ATE458724 T1 AT E458724T1 AT 02739978 T AT02739978 T AT 02739978T AT 02739978 T AT02739978 T AT 02739978T AT E458724 T1 ATE458724 T1 AT E458724T1
Authority
AT
Austria
Prior art keywords
tnf
alpha expression
compounds
heterocyclic inhibitors
disclosed
Prior art date
Application number
AT02739978T
Other languages
English (en)
Inventor
Kevin Moriarty
Yvonne Shimshock
Gulzar Ahmed
Junjun Wu
James Wen
Wei Li
Shawn ERICKSON
Jeffrey Letourneau
Edward Mcdonald
Katerina Leftheris
Stephen Wrobleski
Zahid Hussain
Ian Henderson
Axel Metzger
John Baldwin
Alaric Dyckman
Original Assignee
Bristol Myers Squibb Co
Pharmacopeia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/891,750 external-priority patent/US6906067B2/en
Application filed by Bristol Myers Squibb Co, Pharmacopeia Inc filed Critical Bristol Myers Squibb Co
Priority claimed from PCT/US2002/020212 external-priority patent/WO2003002542A1/en
Application granted granted Critical
Publication of ATE458724T1 publication Critical patent/ATE458724T1/de

Links

AT02739978T 2001-06-26 2002-06-25 N-heterocyclische inhibitoren der expression von tnf-alpha ATE458724T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/891,750 US6906067B2 (en) 1999-12-28 2001-06-26 N-heterocyclic inhibitors of TNF-α expression
PCT/US2002/020212 WO2003002542A1 (en) 2000-12-22 2002-06-25 N-heterocyclic inhibitors of tnf-alpha expression

Publications (1)

Publication Number Publication Date
ATE458724T1 true ATE458724T1 (de) 2010-03-15

Family

ID=31947149

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02739978T ATE458724T1 (de) 2001-06-26 2002-06-25 N-heterocyclische inhibitoren der expression von tnf-alpha

Country Status (7)

Country Link
EP (1) EP1409463B1 (de)
JP (1) JP2004535446A (de)
AT (1) ATE458724T1 (de)
CA (1) CA2451125A1 (de)
DE (1) DE60235470D1 (de)
ES (1) ES2339226T3 (de)
HU (1) HUP0401712A3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2617557A1 (en) * 2005-08-04 2007-02-15 Sirtris Pharmaceuticals, Inc. Benzimidazole derivatives as sirtuin modulators
AU2006319263B2 (en) * 2005-12-01 2012-06-28 Basf Se Method for producing sulfonamides
WO2008016675A1 (en) * 2006-08-01 2008-02-07 Praecis Pharmaceuticals Incorporated P38 kinase inhibitors
AR068849A1 (es) 2007-10-12 2009-12-09 Basf Se Procedimiento para la preparacion de diamidas de acido sulfonico
CN102203064A (zh) * 2008-09-02 2011-09-28 贝林格尔.英格海姆国际有限公司 新的苯甲酰胺，其制备及其作为药物的用途
KR20140049961A (ko) * 2010-11-29 2014-04-28 갈레온 파마슈티칼스, 인코포레이티드 호흡 조절 장애 또는 질병의 치료를 위한 호흡 자극제로서의 신규 화합물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311614B1 (no) * 1996-10-01 2001-12-17 Janssen Pharmaceutica Nv Substituerte diamino-1,3,5-triazinderivater
WO1999001442A1 (en) * 1997-07-02 1999-01-14 Zeneca Limited Triazine derivatives and their use as antibacterial agents
EP1246823A1 (de) * 1999-12-28 2002-10-09 Pharmacopeia, Inc. Pyrimidin- und triazin kinase-hemmer

Also Published As

Publication number Publication date
EP1409463A1 (de) 2004-04-21
JP2004535446A (ja) 2004-11-25
HUP0401712A3 (en) 2009-06-29
DE60235470D1 (de) 2010-04-08
EP1409463A4 (de) 2004-11-17
ES2339226T3 (es) 2010-05-18
CA2451125A1 (en) 2003-01-09
HUP0401712A2 (hu) 2004-12-28
EP1409463B1 (de) 2010-02-24

Similar Documents

Publication Publication Date Title
ATE368034T1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
SE0101675D0 (sv) Novel composition
ATE556713T1 (de) Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
PL406680A1 (pl) Inhibitory kinaz tyrozynowych
DE69836563D1 (de) INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYLSUBSTITUIERTEN HARNSTOFFEN
YU49101A (sh) Karboksiaril supstituisani difenil karbamidi kao inhibitori raf kinaze
BRPI0512547A (pt) pirimidinas
ATE316785T1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
ATE517896T1 (de) P38-kinase-inhibitoren
ATE339418T1 (de) Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
ATE520663T1 (de) Stickstoff atom enthaltenden heteroaryl- harnstoffe als inhibitoren der p38-kinase
DE60316013D1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
ATE478664T1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
DE60222302D1 (de) Inhibitoren von mitotischem kinesin
ATE554087T1 (de) Neue kinaseinhibitoren
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ATE425149T1 (de) ANILINOPYRIMIDIN DERIVATE ALS ßJNK PATHWAY INHIBITORENß, ZUSAMMENSETZUNGEN UND DAMIT VERBUNDENE BEHANDLUNGSMETHODEN
DE60218445D1 (de) Inhibierung der raf-kinase durch chinolin-, isochinolin- oder pyridin-harnstoffe
DE602004018780D1 (de) Inhibitoren von thienopyridin- und furopyridinkinase
WO2004030620A3 (en) Novel tyrosine kinase inhibitors
DE60228073D1 (de) Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen
ATE501128T1 (de) 1,2,3-triazolamidderivate als inhibitoren der cytokinproduktion
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
DK1362045T3 (da) 2-Thio-substituerede imidazolderivater og deres anvendelse inden for farmacien
ATE443044T1 (de) Tace inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties